Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1956 1
1957 1
1961 2
1962 1
1963 1
1964 2
1965 3
1966 4
1967 6
1968 3
1969 6
1970 4
1971 4
1972 5
1973 10
1974 19
1975 15
1976 16
1977 19
1978 21
1979 21
1980 22
1981 24
1982 19
1983 16
1984 26
1985 25
1986 24
1987 23
1988 19
1989 23
1990 32
1991 26
1992 17
1993 25
1994 18
1995 17
1996 28
1997 39
1998 37
1999 36
2000 43
2001 51
2002 57
2003 76
2004 67
2005 110
2006 119
2007 112
2008 142
2009 171
2010 167
2011 155
2012 200
2013 308
2014 297
2015 302
2016 361
2017 350
2018 406
2019 367
2020 531
2021 585
2022 571
2023 577
2024 434

Text availability

Article attribute

Article type

Publication date

Search Results

6,479 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, Van der Meer P, von Lewinski D, Wolf D, Petrie MC; STEP-HFpEF Trial Committees and Investigators. Kosiborod MN, et al. Among authors: verma s. N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25. N Engl J Med. 2023. PMID: 37622681 Clinical Trial.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ; STEP-HFpEF DM Trial Committees and Investigators. Kosiborod MN, et al. Among authors: verma s. N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587233 Clinical Trial.
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.
Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Petrie MC. Kosiborod MN, et al. Among authors: verma s. JACC Heart Fail. 2023 Aug;11(8 Pt 1):1000-1010. doi: 10.1016/j.jchf.2023.05.010. Epub 2023 May 21. JACC Heart Fail. 2023. PMID: 37294245 Free article. Clinical Trial.
Healer's High.
Kalra S, Verma SK, Kapoor N. Kalra S, et al. Among authors: verma sk. J Pak Med Assoc. 2023 Oct;73(10):2114-2115. doi: 10.47391/JPMA.23-73. J Pak Med Assoc. 2023. PMID: 37876085 Free article.
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease.
Primary Panel:; Abramson BL, Al-Omran M, Anand SS, Albalawi Z, Coutinho T, de Mestral C, Dubois L, Gill HL, Greco E, Guzman R, Herman C, Hussain MA, Huckell VF, Jetty P, Kaplovitch E, Karlstedt E, Kayssi A, Lindsay T, Mancini GBJ, McClure G, McMurtry MS, Mir H, Nagpal S, Nault P, Nguyen T, Petrasek P, Rannelli L, Roberts DJ, Roussin A, Saw J, Srivaratharajah K, Stone J, Szalay D, Wan D; Secondary Panel:; Cox H, Verma S, Virani S. Primary Panel:, et al. Among authors: verma s. Can J Cardiol. 2022 May;38(5):560-587. doi: 10.1016/j.cjca.2022.02.029. Can J Cardiol. 2022. PMID: 35537813
Towards a youth mental health paradigm: a perspective and roadmap.
Uhlhaas PJ, Davey CG, Mehta UM, Shah J, Torous J, Allen NB, Avenevoli S, Bella-Awusah T, Chanen A, Chen EYH, Correll CU, Do KQ, Fisher HL, Frangou S, Hickie IB, Keshavan MS, Konrad K, Lee FS, Liu CH, Luna B, McGorry PD, Meyer-Lindenberg A, Nordentoft M, Öngür D, Patton GC, Paus T, Reininghaus U, Sawa A, Schoenbaum M, Schumann G, Srihari VH, Susser E, Verma SK, Woo TW, Yang LH, Yung AR, Wood SJ. Uhlhaas PJ, et al. Among authors: verma sk. Mol Psychiatry. 2023 Aug;28(8):3171-3181. doi: 10.1038/s41380-023-02202-z. Epub 2023 Aug 14. Mol Psychiatry. 2023. PMID: 37580524 Free PMC article. Review.
The cardiovascular effects of novel weight loss therapies.
Usman MS, Davies M, Hall ME, Verma S, Anker SD, Rosenstock J, Butler J. Usman MS, et al. Among authors: verma s. Eur Heart J. 2023 Dec 21;44(48):5036-5048. doi: 10.1093/eurheartj/ehad664. Eur Heart J. 2023. PMID: 37966486 Review.
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.
Verma S, Pandey A, Pandey AK, Butler J, Lee JS, Teoh H, Mazer CD, Kosiborod MN, Cosentino F, Anker SD, Connelly KA, Bhatt DL. Verma S, et al. Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H670-H688. doi: 10.1152/ajpheart.00419.2023. Epub 2023 Dec 22. Am J Physiol Heart Circ Physiol. 2024. PMID: 38133623 Review.
6,479 results